Systolic blood pressure was significantly associated with the presence of diabetic retinopathy in patients with type 1 diabetes (OR 1.05), but not in those with type 2 diabetes.
Cross-Sectional (n=191)
No
Systolic blood pressure is independently associated with the presence of diabetic retinopathy in patients with type 1 diabetes, but not in those with type 2 diabetes.
Effect estimate: OR 1.05 (95% CI 0.99-1.10)
p-value: p=0.045
The aim of this study was to investigate the role of systolic blood pressure (SBP) and diastolic blood pressure (dBP) in the development of diabetic retinopathy (dr) in type 1 and type 2 diabetes and to determine the differences between these two types of diabetes. This cross-sectional study included 84 patients with type 1 diabetes (t1dM) and 107 patients with type 2 diabetes (t2dM). Ophthalmologic retinal examination included indirect slit-lamp fundoscopy, color fundus photography according to eurOdiAB (eurOpe and diABetes) protocol and optical coherence tomography. Blood pressure was measured with a mercury sphygmomanometer after a 10-minute rest period. in t1dM, dr was positively associated with SBP (p = 0.035), hbA1c median (p < 0.001) and hypertensive retinopathy (p < 0.001), while in t2dM dr was positively related only to hbA1c median (p = 0.021). Binary logistic regression analysis (no dr/dr) showed that diabetes duration and hbA1c median were the main predictors of dr in both types of diabetes. in contrast, SBP (Or = 1.05, p = 0.045) and hypertensive retinopathy (Or = 3.75, p < 0.001) were the main predictors/indicators of dr only in t1dM. in conclusion, blood pressure is associated with dr in type 1 but not in type 2 diabetes.
Tomislav Bulum (Sat,) conducted a cross-sectional in Type 1 and Type 2 diabetes mellitus (n=191). Systolic blood pressure was evaluated on Presence of diabetic retinopathy in type 1 diabetes (OR 1.05, 95% CI 0.99-1.10, p=0.045). Systolic blood pressure was significantly associated with the presence of diabetic retinopathy in patients with type 1 diabetes (OR 1.05), but not in those with type 2 diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: